Moderna completes $3.0B convertible notes offering due 2032
Moderna completed a $3.0 billion private offering of 0.00% Convertible Senior Notes due March 1, 2032 and executed the related indenture. Notes are convertible at $210.58 per share, with settlement in cash, stock, or combination.
Moderna completed a $3.0 billion private offering of 0.00% Convertible Senior Notes due March 1, 2032 and entered into the related indenture. The notes are initially convertible at $210.58 per share and may be settled in cash, stock or a combination. The company said it used the transaction to mitigate dilution from potential conversions.